<DOC>
	<DOCNO>NCT00357383</DOCNO>
	<brief_summary>To evaluate ocular tolerance T1225 1 % 1.5 % eye drop versus vehicle one instillation twice-daily ( morning evening ) , one eye , 3 day ( Day 0 Day 2 ) . To assess azithromycin tear , conjunctiva plasmatic concentration , 3-day treatment period</brief_summary>
	<brief_title>Study Ocular Safety After Repeated Instillations T1225 1 % 1.5 % Eye Drops Healthy Volunteers</brief_title>
	<detailed_description>The aim present study compare ocular tolerance safety repeat instillation T1225 1 % 1.5 % eye drop vehicle ass residual azithromycin concentration tear , ocular conjunctiva plasma sample , approximately 12 hour last Investigational Medicinal Product instillation .</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Eye Infections</mesh_term>
	<mesh_term>Eye Infections , Bacterial</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Male female age 18 45 year old ; Written inform consent ; Healthy volunteer without subjective ocular symptom ; Normal ocular examination eye ( correct visual acuity &gt; = 6/10 , normal slit lamp examination , tear prism height &gt; 0.1mm , tear breakup time ( BUT ) &gt; = 10 second , lissamine green test score &lt; 4 ) ; Registered , agree register , national register healthy volunteer Ocular trauma , infection inflammation within last 3 month ; number corneal stain punctuation Ocular trauma , infection inflammation within last 3 month ; number corneal stain punctuation &gt; = 5 ; blepharitis , conjunctivitis , uveitis ; contact lens ; topical ocular treatment within last month ; ocular laser within last 3 month ; ocular surgery , include LASIK PRK , within last 12 month ; systemic macrolide within last month ; medication study ( except : paracetamol contraceptive ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>